XML 130 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Investments (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2021
Jul. 22, 2021
May 13, 2021
Apr. 02, 2021
Mar. 18, 2021
Mar. 15, 2021
Dec. 30, 2020
Dec. 19, 2020
Sep. 10, 2020
Aug. 28, 2020
Oct. 10, 2019
Feb. 28, 2022
Sep. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Mar. 31, 2022
Jun. 18, 2021
Unrealized Gain/(Loss)                               $ 3,042,000   $ 1,544,000    
Debt interest rate                                       4.25%
Investments                           $ 9,158,000   9,158,000   4,341,000    
Gain (loss) on investments                           3,399,000 $ (6,821,000) 3,823,000 $ (7,898,000)      
Investment, equity method                           982,000   982,000   1,080,000    
Net Income (Loss) Attributable to Parent                           (4,652,000) $ (8,418,000) (12,700,000) (12,399,000)      
Vivacitas Agreement [Member]                                        
Share-based compensation arrangement by share-based payment award, options, exercises in period   1,000,000                                    
Stock issued during period, value, stock options exercised   $ 1,000,000                                    
Increase in shares   120,000                                    
Investment cost                           4,100,000   4,100,000   4,035,000    
Security Purchase Agreement [Member]                                        
Debt interest rate 10.00%                       10.00%              
Maturity date                         Sep. 09, 2024              
Investment, equity method $ 1,400,000                       $ 1,400,000              
Convertible notes payable 1,400,000                       1,400,000              
Origination fee                         $ 500,000              
Security Purchase Agreement [Member] | GTNW [Member]                                        
Unrealized Gain/(Loss)                           4,865,354            
Number of shares of common stock                         154,173              
Membership Unit Purchase Agreement [Member]                                        
Stock issued for acquisition, values 1,537,000                                      
Impairment of investment                               1,537,000        
Common Stock [Member]                                        
New shares Issued                               $ 80,000 $ 1,104,000      
Number of shares of common stock                       44,619,423       3,987,000 55,184,000      
BMI Capital International LLC [Member]                                        
Investment, equity method                           $ 26,000   $ 26,000        
Oncology P T E Ltd [Member]                                        
Options to purchase additional shares         250,000                              
Consideration transferred         $ 2,480,000                              
Sentinel Brokers Company Inc [Member]                                        
Investments $ 1,050,000   $ 750,000                   $ 1,050,000              
Outstanding membership interest     50.10%                                  
Consideration transferred     $ 300,000                                  
Outstanding Remaining Membership Interest     25.00%                                  
[custom:AdditionalMembershipInterest]     50.10%                                  
Net Income (Loss) Attributable to Parent                               $ 185,000        
Onwership Increment [Member] | BMI Capital International LLC [Member]                                        
Ownership percentage                 24.90%                      
BioMed Technologies Asia Pacific Holdings Limited [Member]                                        
Ownership percentage               4.99%                        
New shares Issued               $ 632,000                        
Number of shares of common stock               525                        
Common Shares [Member] | Vivacitas Agreement [Member]                                        
Ownership percentage                           16.00%   16.00%        
Purchase Agreement [Member] | Sentinel Brokers Company Inc [Member]                                        
Ownership percentage     24.90%                                  
Investment Equity [Member] | Sentinel Brokers Company Inc [Member]                                        
Ownership percentage                           24.90%   24.90%        
Ownership Limited Liability Company [Member]                                        
Ownership percentage 30.75%                       30.75%              
Minimum [Member]                                        
Debt interest rate                                       4.25%
Minimum [Member] | Onwership Increment [Member] | BMI Capital International LLC [Member]                                        
Ownership percentage                 20.00%                      
Alset International Limited [Member]                                        
Owners shares                           127,179,311   127,179,311        
Outstanding share percentage                               7.00%        
Singapore eDevelopment Limited [Member]                                        
Marketable securities                           $ 3,841,000   $ 3,841,000   4,909,000    
Unrealized Gain/(Loss)                               1,068,000 $ 967,000      
Century TBD Holdings, LLC [Member]                                        
Outstanding principal and interest                     $ 500,000                  
Debt interest rate                     6.00%                  
Maturity date                     Oct. 09, 2021                  
Debt instrument, periodic payment                                   $ 537,000    
Century TBD Holdings, LLC [Member] | Maximum [Member]                                        
Outstanding principal and interest                     $ 500,000                  
Convertible, threshold percentage                     19.80%                  
West Park Capital Inc [Member]                                        
Convertible, threshold percentage             7.50%                          
Investments                                     $ 500,000  
Gain (loss) on investments                               $ 37,000        
DSS Securities, Inc. [Member]                                        
New shares Issued                 $ 100,000                      
Outstanding membership interest                 10.00%                      
Acquistion description                   On or about August 28, 2020, the Company’s wholly owned subsidiary, DSS Securities, Inc. entered into a corporate venture to form and operate a real estate title agency, under the name of Alset Title Company, Inc, a Texas corporation (“ATC”). DSS Securities, Inc. shall own 70% of this venture with the other two shareholders being attorneys necessary to the state application and permitting process. The Company’s CEO, who is a licensed attorney, has a stated non-compensated 15% ownership interest in the venture. There was minimal activity for the six months ended June 30, 2022.           On or about August 28, 2020, the Company’s wholly owned subsidiary, DSS Securities, Inc. entered into a corporate venture to form and operate a real estate title agency, under the name of Alset Title Company, Inc, a Texas corporation (“ATC”). DSS Securities, Inc. shall own 70% of this venture with the other two shareholders being attorneys necessary to the state application and permitting process. The Company’s CEO, who is a licensed attorney, has a stated non-compensated 15% ownership interest in the venture. There was minimal activity for the six months ended June 30, 2022.        
DSS Securities, Inc. [Member] | Onwership Increment [Member]                                        
Ownership percentage                 14.90%                      
Vivacitas Oncology Inc [Member]                                        
Number of shares of common stock           500,000                            
Options to purchase additional shares           1,500,000                            
Issued price per share           $ 1.00                            
Additional price per share           $ 1.00                            
Consideration transferred       $ 120,000                                
Sale of stock, description       the Company entered into an additional stock purchase agreement with Vivacitas (“Vivacitas Agreement #2”), whereas Vivacities wished to employ the service of the Chief Business Officer of Impact Biomedical, and in return for the services of this individual, Vivacitas shall issue to the Company, the aggregate purchase price for the Class A Common Shares of Vivacitas at the value of $1.00 per share shall be $120,000 to be paid in twelve (12) equal monthly installments for the period between April 1, 2021 and March 31, 2022.                                
Vivacitas Oncology Inc [Member] | Common Stock [Member]                                        
Options to purchase additional shares           500,000                            
Issued price per share           $ 1.00                            
Oncology P T E Ltd [Member]                                        
Owners shares         2,480,000